Tirofiban Combination Therapy for Acute Ischemic Stroke: A Systematic Review and Meta‐Analysis
<h3>Introduction</h3><p dir="ltr">Acute ischemic stroke (AIS) is a leading cause of morbidity and mortality globally. Standard antiplatelet therapies, while partially effective, do not fully inhibit all pathways of platelet aggregation, leaving patients at risk of recurre...
Saved in:
| Main Author: | Abdullah Bin Kamran (22565237) (author) |
|---|---|
| Other Authors: | Ahmed Bazil Bin Khalil (22565240) (author), Ayesha Muhammad (18702111) (author), Hira Arshad (22565243) (author), Fatima Nazir (22565246) (author), Muhammad Mateen Ali (22565249) (author), M. Mairaj Umar (22565252) (author), Muhammad Farhan (4454434) (author), Sudhair Alam (22565255) (author), Javed Iqbal (2121922) (author) |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and efficacy of tirofiban in the management of stroke: A systematic review and meta-analysis of randomized controlled trials
by: Mohammed Maan Al-Salihi (13105835)
Published: (2023) -
Circulating MicroRNA Profiling Identifies Distinct MicroRNA Signatures in Acute Ischemic Stroke and Transient Ischemic Attack Patients
by: Salman M. Toor (8854751)
Published: (2022) -
There Is Selective Increase in Pro-thrombotic Circulating Extracellular Vesicles in Acute Ischemic Stroke and Transient Ischemic Attack: A Study of Patients From the Middle East and Southeast Asia
by: Abdelali Agouni (181926)
Published: (2019) -
Transradial versus transfemoral artery access in mechanical thrombectomy for acute ischemic stroke: An updated systematic review and meta-analysis
by: Amjad Almansi (17738179)
Published: (2024) -
Implementing CYP2C19 Pharmacogenetic Testing for Personalized Antiplatelet Therapy: Findings From the QPGx-CARES Initiative
by: Rania Abdel-latif (18295396)
Published: (2025)